Logo

Co-Diagnostics: Mark Poritz

Nov 01, 2022

Co-Diagnostics has appointed Mark Poritz as CSO. Poritz most recently served as CSO of Idaho Molecular, which Co-Diagnostics acquired at the end of 2021. He previously worked at BioFire Diagnostics (now part of BioMérieux) from 2002 to 2018, playing a key role in the company's growth and development of the FilmArray in vitro diagnostic testing platform, Co-Diagnostics said. The company added that Poritz is a Harvard University- and University of California, San Francisco-educated molecular biologist with more than 30 years of experience in the application of PCR and related methods to gene cloning, drug discovery, infectious disease diagnostics, and aptamer selection.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.